Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.